文献速递头颈外科咽喉与嗓音

头颈癌调强放疗前喂养管使用风险分层

Pretreatment risk stratification of feeding tube use in patients treated with intensity-modulated radiotherapy for head and neck cancer.
PubMed 文献 · Head Neck · 2018-05-13

多因素分析显示,T分期≥3和2区淋巴结肿大分别是口腔、咽及声门上原发肿瘤中喂养管使用风险更高和持续时间更长的独立预测因素。结论认为这两项因素可将患者分为4个需要喂养管的重度吞咽困难风险组。

要点

  • T分期≥3和2区淋巴结肿大是IMRT前喂养管使用的独立预测因素。
  • 基于上述因素可将患者分为4个喂养管使用风险组。
  • 研究建议根治性IMRT患者预防性放置喂养管并由营养师随访至少8周。

核心结论

  • 在根治性IMRT的头颈癌患者中,T分期≥3和2区淋巴结肿大可潜在将患者分为4个需要喂养管的重度吞咽困难风险组。

主要发现

  • 单因素分析中多个变量对喂养管使用风险和/或持续时间有显著影响。
  • 多因素分析显示,在口腔、咽及声门上原发肿瘤中,T分期≥3是喂养管使用风险更高的独立预测因素。
  • 多因素分析显示,2区淋巴结肿大是喂养管使用持续时间更长的独立预测因素。

关键数值与推荐

  • 喂养管使用定义为至少满足25%饮食需求。
  • 患者被推荐预防性放置喂养管并由营养师随访至少放疗后8周。

临床怎么用

  • 对具有T分期≥3或2区淋巴结肿大的头颈癌IMRT患者,可考虑预防性喂养管放置和密切营养随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The purpose of this study was to establish a risk stratification model for feeding tube use in patients who undergo intensity-modulated radiotherapy (IMRT) for head and neck cancers. METHODS: One hundred thirty-nine patients treated with definitive IMRT (+/- concurrent chemotherapy) for head and neck mucosal cancers were included in this study. Patients were recommended a prophylactic feeding tube and followed up by a dietician for at least 8 weeks postradiotherapy (post-RT). Potential prognostic factors were analyzed for risk and duration of feeding tube use for at least 25% of dietary requirements. RESULTS: Many variables had significant effects on risk and/or duration of feeding tube use in univariate analyses. Subsequent multivariable analysis showed that T classification ≥3 and level 2 lymphadenopathy were the best independent significant predictors of higher risk and duration of feeding tube use, respectively, in oral cavity, pharyngeal, and supraglottic primaries. CONCLUSION: In patients treated with definitive IMRT, T classification ≥3 and level 2 lymphadenopathy can potentially stratify patients into 4 risk groups for developing severe dysphagia requiring feeding tube use.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Anderson NJ, Jackson JE, Smith JG, et al. Pretreatment risk stratification of feeding tube use in patients treated with intensity-modulated radiotherapy for head and neck cancer. Head Neck. 2018. PMID: 29756389. doi:10.1002/hed.25316

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。